Serum leptin concentrations in women taking oral contraceptives

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 83, Issue 1, 1999, Pages 105-108

  Rechberger, Tomasz ^a   Baranowski, Wlodzimierz ^a   Postawski, Krzysztof ^a   Jakimiuk, Artur J ^a   Tomaszewski, Jacek ^a   Kulik Rechberger, Beata ^a   Jakowicki, Jerzy A ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Desogestrel; Leptin; Oral contraceptives

Indexed keywords

DESOGESTREL; DESOGESTREL PLUS ETHINYLESTRADIOL; ETHINYLESTRADIOL; GESTAGEN; LEPTIN; ORAL CONTRACEPTIVE AGENT;

ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; NORMAL HUMAN; OBESITY; ORAL CONTRACEPTION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; STATISTICAL ANALYSIS;

EID: 0033038927     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(98)00309-1     Document Type: Article

References (24)

1. Mitchell C, editor. Clinical Gynecologic Endocrinology and Infertility. Baltimore: Williams and Wilkins, 1994:651-666.
2. Green B.B., Weiss N.S., Daling J.R. Risk of ovulatory infertility in relation to body weight. Fertil Steril. 50:1988;721-726.
3. De Souza M.I., Metzger D.A. Reproductive dysfunction in amenorrheic athltetes and anorexic patients: a review. Med Sci Sports Exerc. 23:1991;995-1007.
4. Stein I.F., Leventhal M.L. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol. 29:1935;181-186.
5. Zhang Y., Proenca R., Maffei M.et al. Positional cloning of the mouse obese gene and its human homologue. Nature. 372:1994;425-432.
6. Cioffi J.A., Shafer A.W., Zupancic T.J.et al. Novel B219.OB receptor isoforms: possible role of leptin in hematopoeiesis and reproduction. Nature Med. 2:1996;585-589.
7. Lee G., Proenca R., Montez J.M.et al. Abnormal splicing of the leptin receptor in diabetic mice. Nature. 379:1996;632-635.
8. Tartaglia L.A., Dembski M., Weng X.et al. Identification and expression cloning of a leptin receptor OB-R. Cell. 83:1995;1263-1271.
9. Zachow R.J., Magoffin D.A. Direct intraovarian effects of leptin: Impairment of the synergistic action of insulin-like growth factor-I on follicle-stimulating hormone-dependent estradiol-17 beta production by rat ovarian granulosa cells. Endocrinology. 138:1997;847-850.
10. Weigle D., Bukowski T., Foster D.et al. Recombinant ob protein reduces feeding and body weight in the ob/ob mouse. J Clin Invest. 96:1995;2065-2070.
11. Halaas J., Gajiwala K., Maffei M.et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 269:1995;543-546.
12. Pelleymounter M., Cullen M., Baker M.et al. Effects of the obese gene product on the body weight regulation in ob/ob mice. Science. 269:1995;540-543.
13. Considine R.V., Sinha M.K., Heiman M.L.et al. Serum immunoreactive-leptin concentrations in normal and obese human. N Engl J Med. 334:1996;292-295.
14. Kulik-Rechberger B, Rechberger T, Jakimiuk AJ. Leptin correlates with the skin fold thickness in prepubertal and pubertal girls. Acta Paediatrica (accepted for publication, Feb. 1998).
15. Maffei M., Halaas J., Ravussin E.et al. Leptin levels in human and rodents: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med. 1:1995;1155-1161.
16. Chehab F.F., Lim M.E., Lu R. Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nat Genet. 12:1996;318-320.
17. Akerlund M., Rode A., Westergaard J. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 μg desogestrel and either 30 μg or 20 μg ethinyl estradiol. Br J Obstet Gynaecol. 100:1993;832-838.
18. Kojima T., Lindheim S.R., Duffy D.M., Vijod M.A., Stanczyk F., Lobo R.A. Insulin sensitivity is decreased in normal women by doses of ethinyl estradiol used in oral contraceptive. Am J Obstet Gynecol. 169:1993;1540-1544.
19. Godsland I.F., Walton C., Felton C., Prouder A., Patel A., Wynn V. Insulin resistance, secretion and metabolism in users of oral contraceptives. J Clin Endocrinol Metab. 74:1991;64-70.
20. Srivastava M.C., Oakley N.W., Tompkins C.V., Sonksen P.H., Wynn V. Insulin metabolism, insulin sensitivity and hormonal responses to insulin infusion in patients taking oral contraceptive steroids. Eur J Clin Invest. 5:1975;425-433.
21. Barash I.A., Cheung C.C., Weigle D.S.et al. Leptin is a metabolis signal to the reproductive system. Endocrinology. 137:1996;3144-3147.
22. Nader S., Riad-Gabriel M.G., Saad M.F. The effect of a desogestrel-containing oral contraceptive on glucose tolerance and leptin concentrations in hyperandrogenic women. J Clin Endocrinol Metab. 82:1997;3074-3077.
23. Rubio-Lotvin B. The desogestrel-ethinyl estradiol combination and overweight: current data. Ginecol Obstet Mex. 63:1995;483-486.
24. Haffner S.M., Mykkanen L., Stern M.P. Leptin concentrations in women in the San Antonio Heart Study: effect of menopausal status and postmenopausal hormone replacement therapy. Am J Epidemiol. 146:1997;581-585.